Clobetasol Propionate Cream 0.05%
Generic Name: clobetasol propionate cream 0.05%
Brand Names:
Clobetasol Propionate Cream 0.05% Clobetasol Propionate Cream 0.05%
DESCRIPTION: Clobetasol Propionate Cream USP contains the active compound clobetasol propionate, a synthetic corticosteroid, for topical dermatologic use. Clobetasol, an analog of prednisolone, has a high degree of glucocorticoid activity and a slight degree of mineralocorticoid activity.
Overview
DESCRIPTION: Clobetasol Propionate Cream USP contains the active compound clobetasol propionate, a synthetic corticosteroid, for topical dermatologic use. Clobetasol, an analog of prednisolone, has a high degree of glucocorticoid activity and a slight degree of mineralocorticoid activity.
Uses
INDICATIONS AND USAGE: Clobetasol propionate cream USP, 0.05% is super-high potency corticosteroid formulation indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Treatment beyond 2 consecutive weeks is not recommended, and the total dosage should not exceed 50 g /week because of the potential for the drug to suppress the hypothalamic-pituitary- adrenal (HPA) axis. Use in pediatric patients under 12 years of age is not recommended. As with other highly active corticosteroids, therapy should be discontinued when control has been achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.
Dosage
DOSAGE AND ADMINISTRATION: Apply a thin layer of clobetasol propionate cream to the affected skin areas twice daily and rub in gently and completely (See INDICATIONS AND USAGE). Clobetasol propionate cream is super- high potency topical corticosteroids; therefore, treatment should be limited to 2 consecutive weeks and amounts greater than 50 g/week should not be used . As with other highly active corticosteroids, therapy should be discontinued when control has been achieved. If no improvement is seen within 2 weeks, reassessment of diagnosis may be necessary. Clobetasol propionate cream should not be used with occlusive dressings.
Side Effects
ADVERSE REACTIONS: In controlled clinical trials, the most frequent adverse reactions reported for clobetasol propionate cream were burning and stinging sensation in 1% of treated patients. Less frequent adverse reactions were itching, skin atrophy, and cracking and fissuring of the skin. Cushing's syndrome has been reported in infants and adults as a result of prolonged use of topical clobetasol propionate formulations. The following additional local adverse reactions have been reported with topical corticosteroids, and they may occur more frequently with the use of occlusive dressings and higher potency corticosteroids.
Warnings
CONTRAINDICATIONS: Clobetasol propionate cream USP, 0.05% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.
Pregnancy
Pregnancy: Teratogenic Effects: Pregnancy Category C corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. Some corticosteroids have been shown to be teratogenic after dermal application to laboratory animals. Clobetasol propionate has not been tested for teratogenicity when applied topically; however, it is absorbed percutaneously, and when administered subcutaneously it was a significant teratogen in both the rabbit and mouse.
Storage
HOW SUPPLIED: Clobetasol Propionate Cream USP, 0.05% is supplied in 60 g tube NDC 68788-4001-6 Store cream between 15° and 30°C (59°-86°F). Clobetasol propionate cream should not refrigerated. Made in Italy, formulated in India. Manufactured by: Encube Ethicals Pvt. Ltd. Plot No. C-1, Madkaim Industrial Estate, Madkaim, Post: Mardol, Ponda, Goa - 403 404, India.
Frequently Asked Questions
What is Clobetasol Propionate Cream 0.05% used for?▼
INDICATIONS AND USAGE: Clobetasol propionate cream USP, 0.05% is super-high potency corticosteroid formulation indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Treatment beyond 2 consecutive weeks is not recommended, and the total dosage should not exceed 50 g /week because of the potential for the drug to suppress the hypothalamic-pituitary- adrenal (HPA) axis. Use in pediatric patients under 12 years of age is not recommended. As with other highly active corticosteroids, therapy should be discontinued when control has been achieved. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary.
What are the side effects of Clobetasol Propionate Cream 0.05%?▼
ADVERSE REACTIONS: In controlled clinical trials, the most frequent adverse reactions reported for clobetasol propionate cream were burning and stinging sensation in 1% of treated patients. Less frequent adverse reactions were itching, skin atrophy, and cracking and fissuring of the skin. Cushing's syndrome has been reported in infants and adults as a result of prolonged use of topical clobetasol propionate formulations. The following additional local adverse reactions have been reported with topical corticosteroids, and they may occur more frequently with the use of occlusive dressings and higher potency corticosteroids.
Can I take Clobetasol Propionate Cream 0.05% during pregnancy?▼
Pregnancy: Teratogenic Effects: Pregnancy Category C corticosteroids have been shown to be teratogenic in laboratory animals when administered systemically at relatively low dosage levels. Some corticosteroids have been shown to be teratogenic after dermal application to laboratory animals. Clobetasol propionate has not been tested for teratogenicity when applied topically; however, it is absorbed percutaneously, and when administered subcutaneously it was a significant teratogen in both the rabbit and mouse.
What are the important warnings for Clobetasol Propionate Cream 0.05%?▼
CONTRAINDICATIONS: Clobetasol propionate cream USP, 0.05% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations.
Related Medications
Tucatinib
tucatinib
Kinase Inhibitor [EPC]
11 DESCRIPTION Tucatinib is a kinase inhibitor. The chemical name is (N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine. The molecular formula is C 26 H 24 N 8 O 2 and the molecular weight is 480.52 g/mol.
Ascorbicum Acidum, Pyridoxinum Hydrochloricum, Riboflavinum, Sarcolacticum Acidum, Thiaminum Hydrochloricum, Dhea (dehydroepiandrosterone), Adenosinum Triphosphoricum Dinatrum, Alpha-lipoicum Acidum, Citricum Acidum, Fumaricum Acidum, Nadidum, Pantothenic Acid, Acetaldehyde, Insulinum (suis), Insulinum (human), Hepar Suis, Pancreas Suis, Phloridzinum, Alloxanum, Berberis Vulgaris, Carcinosin, Lycopodium Clavatum, Momordica Balsamina, Phosphoricum Acidum, Phosphorus, Syzygium Jambolanum,
ascorbicum acidum, pyridoxinum hydrochloricum, riboflavinum, sarcolacticum acidum, thiaminum hydrochloricum, dhea (dehydroepiandrosterone), adenosinum triphosphoricum dinatrum, alpha-lipoicum acidum, citricum acidum, fumaricum acidum, nadidum, pantothenic acid, acetaldehyde, insulinum (suis), insulinum (human), hepar suis, pancreas suis, phloridzinum, alloxanum, berberis vulgaris, carcinosin, lycopodium clavatum, momordica balsamina, phosphoricum acidum, phosphorus, syzygium jambolanum,
Calculi Dissolution Agent [EPC]
PURPOSE: Acetaldehyde - Thirst, Adenosinum Triphosphoricum Dinatrum – Dry Mouth, Alloxanum – Sugar Cravings, Alpha-Lipoicum Acidum – Night Sweats, Ascorbic Acid – Sugar Cravings, Barium Oxalsuccinicum – Sugar Cravings, Berberis Vulgaris - Thirst, Carcinosin – Carbohydrate Cravings, Citricum Acidum – Dry Mouth, DHEA (Dehydroepiandrosterone) – Night Sweats, Fumaricum Acidum – Sugar Cravings, Gaertner Bacillus (Bach) – Night Sweats, Gymnema Sylvestre - Thirst, Hepar Suis – Dry Mouth, Insulinum – Ni
Dried Aluminum Hydroxide Sorbitol Blend
dried aluminum hydroxide sorbitol blend
Dosage form: POWDER. Active ingredients: ALUMINUM HYDROXIDE (61.5 kg/100kg); CARBON DIOXIDE (5 kg/100kg). Category: DRUG FOR FURTHER PROCESSING.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.